Application 013174

Type
NDA
Sponsor
CONCORDIA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DYRENIUMTRIAMTERENECAPSULE;ORAL50MGYesNo
002DYRENIUMTRIAMTERENECAPSULE;ORAL100MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N013174-001DYRENIUMTRIAMTERENE50MGCAPSULE / ORALABRLD, Approved before 1982
N013174-002DYRENIUMTRIAMTERENE100MGCAPSULE / ORALABRLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
N013174-001AB
N013174-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N013174-001DYRENIUM50MGCAPSULE / ORALABRLD, Approved before 19823a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N013174-002DYRENIUM100MGCAPSULE / ORALABRLD, RS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N013174-001DYRENIUM50MGCAPSULE / ORALABRLD, Approved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N013174-002DYRENIUM100MGCAPSULE / ORALABRLD, RS, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N013174-001DYRENIUM50MGCAPSULE / ORALABRLD, Approved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N013174-002DYRENIUM100MGCAPSULE / ORALABRLD, RS, Approved before 1982e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N013174-001DYRENIUM50MGCAPSULE / ORALABRLD, Approved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N013174-002DYRENIUM100MGCAPSULE / ORALABRLD, RS, Approved before 1982cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N013174-001DYRENIUM50MGCAPSULE / ORALABRLD, Approved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N013174-002DYRENIUM100MGCAPSULE / ORALABRLD, RS, Approved before 1982a50c72e98297…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N013174-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10N013174-002AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09N013174-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09N013174-002AB1c2088c7a36db…
2026-09-14 22:38:342026-08N013174-001AB184e616aacf4f…
2026-09-14 22:38:342026-08N013174-002AB184e616aacf4f…
2026-08-18 06:07:402026-07N013174-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N013174-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N013174-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N013174-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N013174-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N013174-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N013174-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N013174-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N013174-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N013174-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N013174-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N013174-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N013174-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N013174-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N013174-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N013174-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N013174-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N013174-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N013174-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N013174-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N013174-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10N013174-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N013174-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N013174-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N013174-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N013174-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N013174-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N013174-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N013174-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05N013174-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N013174-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N013174-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N013174-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N013174-002AB15d02ea3f76ae…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DyreniumTRIAMTERENEAdvanz Pharma (US) Corp.ebb177c0-d45d-4443-a85a-e76bd9931a422024-12-05Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 013174
application number: NDA013174
ndc (product): 59212-002
ndc (product): 59212-003
triamtereneTRIAMTERENEPrasco Laboratoriesa09c2212-1dd5-4fbe-ad09-2a57aeabcaea2023-07-03Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 013174
application number: NDA013174
ndc (product): 66993-832
ndc (product): 66993-831

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 21 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
59212-002DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
59212-002DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
59212-002DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
59212-002DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
59212-002DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
59212-003DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
59212-003DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
59212-003DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
59212-003DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
59212-003DyreniumTriamtereneConcordia Pharmaceuticals Inc.NDACurrent
65197-002DyreniumTriamtereneWellSpring Pharmaceutical CorporationNDACurrent
65197-003DyreniumTriamtereneWellSpring Pharmaceutical CorporationNDACurrent
66993-831triamtereneTriamterenePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
66993-831triamtereneTriamterenePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
66993-831triamtereneTriamterenePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
66993-831triamtereneTriamterenePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
66993-832TriamtereneTriamterenePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
66993-832TriamtereneTriamterenePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
66993-832TriamtereneTriamterenePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
66993-832TriamtereneTriamterenePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
68151-1494DyreniumTriamtereneCarilion Materials ManagementNDACurrent